The funds will be used to accelerate commercialization of a highly sensitive, fluorescent version of PBM's Status ™ COVID-19/Flu A&B antigen test used in conjunction with C2Sense's Halo ™ diagnostic reader. WATERTOWN, Mass. and ...
WuXi Biologics is the manufacturing partner of InflaRx for Gohibic (vilobelimab), a first-in-class monoclonal anti-C5a antibody. InflaRx received emergency use authorization (EUA) from the FDA for Gohibic (vilobelimab) for the treatment of ...
The shift from pandemic to endemic doesn't alleviate all concerns as nations worldwide continue to manage COVID-19 along with other respiratory viruses and diseases. This includes maintaining and strengthening commitments to in vitro diagnostic ...
Study Reveals Electroluminescent Film-Based Fingerprint Scanners Are One of the Safest Things to Touch in Public COLUMBIA, Mo. , May 9, 2023 /PRNewswire/ -- Researchers at the University of Missouri Laboratory for Infectious ...
CHICAGO, May 02, 2023 (GLOBE NEWSWIRE) -- An international design competition is underway for a Covid memorial monument. The winning design will be awarded $20,000 USD. A distinguished panel of judges will make the selection. The final ...
GERMANTOWN, Md. and GUANGZHOU, China , April 27, 2023 /PRNewswire/ -- RNAimmune, Inc. (the " Company " or " RNAimmune "), a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, ...
OEGSTGEEST, The Netherlands , April 27, 2023 /PRNewswire/ -- ISA Pharmaceuticals, B.V., a clinical stage biotech company developing immunotherapies to treat cancers and infectious diseases, is pleased to announce that it will be ...
TUCSON, Ariz. , March 30, 2023 /PRNewswire/ -- Updated guidance on COVID vaccination by the World Health Organization (WHO) states that only high-risk groups should receive ongoing booster doses because they offer little impact in the ...
BEIJING , March 25, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of the Dominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the ...
BEIJING , March 24, 2023 /PRNewswire/ -- China has entered a new phase of epidemic prevention and control after it downgraded the management of COVID-19 response into Class B infectious diseases. "The overall situation of epidemic response ...
Long COVID is draining the economy by billions every year, as workers battle persistent symptoms and face challenges returning to their jobs, reports a new study led by UCL researchers. ...
A new clinical study reveals that an inhibitor of Fas ligand (FasL), also known as CD95 ligand (CD95L), could be the latest game-changing treatment for COVID-19....
Researchers are utilizing AI to detect long COVID symptoms, monitor their progression, and rule out other potential causes. This innovative approach suggests that a substantial 22.8% of the population may be affected by long-term COVID-19 ...
A study led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) explores public trust in COVID-19 vaccine science and its influence on vaccine acceptance ...
A new study reveals a concerning link between COVID-19 and dyslipidemia. The pandemic led to a 29% increase in dyslipidemia risk, especially among seniors and people with type 2 diabetes. This condition, characterized by abnormal blood lipid levels, significantly elevates the risk of heart attack and stroke. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers